Cargando…
Glibenclamide for the Treatment of Ischemic and Hemorrhagic Stroke
Ischemic and hemorrhagic strokes are associated with severe functional disability and high mortality. Except for recombinant tissue plasminogen activator, therapies targeting the underlying pathophysiology of central nervous system (CNS) ischemia and hemorrhage are strikingly lacking. Sur1-regulated...
Autores principales: | Caffes, Nicholas, Kurland, David B., Gerzanich, Volodymyr, Simard, J. Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394459/ https://www.ncbi.nlm.nih.gov/pubmed/25749474 http://dx.doi.org/10.3390/ijms16034973 |
Ejemplares similares
-
Glibenclamide for the Treatment of Acute CNS Injury
por: Kurland, David B., et al.
Publicado: (2013) -
The Protective Effect of Glibenclamide in a Model of Hemorrhagic Encephalopathy of Prematurity
por: Tosun, Cigdem, et al.
Publicado: (2013) -
Glibenclamide—10-h Treatment Window in a Clinically Relevant Model of Stroke
por: Simard, J. Marc, et al.
Publicado: (2012) -
Inducible nitric oxide synthase (NOS-2) in subarachnoid hemorrhage: Regulatory mechanisms and therapeutic implications
por: Iqbal, Sana, et al.
Publicado: (2016) -
Heparin Reduces Neuroinflammation and Transsynaptic Neuronal Apoptosis in a Model of Subarachnoid Hemorrhage
por: Simard, J. Marc, et al.
Publicado: (2012)